Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Production and assay of the interleukins.

× No keyword cloud information.

23 in total

1. Conditioned medium from concanavalin A-stimulated spleen cells inhibits the IgE-dependent sensitization of murine peritoneal mast cells in vitro.

Authors: J W Coleman
Journal: Immunology Date: 1990-01 Impact factor: 7.397

2. Defective autologous mixed leukocyte reaction in newly diagnosed type 1 diabetes mellitus.

Authors: L Räsänen; H Hyöty; M Lehto; O P Kallioniemi; J Antonen; T Huupponen; J Karjalainen; P Leinikki
Journal: Clin Exp Immunol Date: 1988-03 Impact factor: 4.330

3. Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease.

Authors: D Hasdai; M Scheinowitz; E Leibovitz; S Sclarovsky; M Eldar; V Barak
Journal: Heart Date: 1996-07 Impact factor: 5.994

4. Liposomal induction of a heat-stable macrophage priming factor to induce nitric oxide in response to LPS.

Authors: Y Aramaki; H Arima; T Hara; S Tsuchiya
Journal: Pharm Res Date: 1996-09 Impact factor: 4.200

5. The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes.

Authors: Y Aramaki; M Murai; S Tsuchiya
Journal: Immunology Date: 1993-10 Impact factor: 7.397

6. Serum levels of IL-1, IL-6 and tumour necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy.

Authors: N Lahat; A Y Zlotnick; R Shtiller; I Bar; G Merin
Journal: Clin Exp Immunol Date: 1992-08 Impact factor: 4.330

Production and assay of the interleukins.

1. Conditioned medium from concanavalin A-stimulated spleen cells inhibits the IgE-dependent sensitization of murine peritoneal mast cells in vitro.

2. Defective autologous mixed leukocyte reaction in newly diagnosed type 1 diabetes mellitus.

3. Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease.

4. Liposomal induction of a heat-stable macrophage priming factor to induce nitric oxide in response to LPS.

5. The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes.

6. Serum levels of IL-1, IL-6 and tumour necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy.

Review 7. Exercise and the immune system. Natural killer cells, interleukins and related responses.

8. Proliferation in vitro of Lyt2-,L3T4- thymocytes shows responsiveness to interleukin 1.

9. Modulation of the IL-2 production defect in vitro in Graves' disease.

10. Psychological and immunological correlates of acute overtraining.